Clinical Trial

Neuropathic Pain, Catastrophizing, and Adherence in SAIS

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Subacromial impingement syndrome is one of the most common causes of shoulder pain and may negatively affect daily activities and quality of life. While shoulder pain is usually considered nociceptive, some patients may also have a neuropathic pain component, which can influence symptom severity and treatment outcomes. In addition, psychological factors such as pain catastrophizing and adherence-related behavior may play an important role in recovery. This prospective observational study aims to evaluate the presence of neuropathic pain in patients with subacromial impingement syndrome and to investigate its relationship with pain catastrophizing and adherence-related behavior. Patients undergoing a standard physical therapy program will be assessed at the beginning and after completion of treatment using validated clinical scales. The findings of this study may help to better understand the interaction between pain characteristics, psychological factors, and adherence-related behavior, and contribute to the development of more individualized rehabilitation strategies
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-09
Trial Details
NCT Number NCT07509021
Lead Sponsor Abant Izzet Baysal University
Conditions Subacromial Impingement Syndrome
Enrollment 75 participants
Start Date 2026-04-02
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-08